2seventy Bio Stock Price Prediction

TSVT Stock  USD 3.99  0.03  0.76%   
The RSI of 2Seventy Bio's share price is below 30 at this time. This usually implies that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling 2Seventy Bio, making its price go up or down.

Oversold Vs Overbought

27

 
Oversold
 
Overbought
The successful prediction of 2Seventy Bio's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with 2Seventy Bio, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting 2Seventy Bio's stock price prediction:
EPS Estimate Next Quarter
(0.18)
EPS Estimate Current Year
(0.72)
EPS Estimate Next Year
(1.01)
Wall Street Target Price
8.25
EPS Estimate Current Quarter
(0.24)
Using 2Seventy Bio hype-based prediction, you can estimate the value of 2Seventy Bio from the perspective of 2Seventy Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in 2Seventy Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying 2Seventy because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

2Seventy Bio after-hype prediction price

    
  USD 4.01  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out 2Seventy Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 2Seventy Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
2.897.0411.19
Details
5 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.18-0.18-0.18
Details

2Seventy Bio After-Hype Price Prediction Density Analysis

As far as predicting the price of 2Seventy Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in 2Seventy Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of 2Seventy Bio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

2Seventy Bio Estimiated After-Hype Price Volatility

In the context of predicting 2Seventy Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on 2Seventy Bio's historical news coverage. 2Seventy Bio's after-hype downside and upside margins for the prediction period are 0.20 and 8.16, respectively. We have considered 2Seventy Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.99
4.01
After-hype Price
8.16
Upside
2Seventy Bio is slightly risky at this time. Analysis and calculation of next after-hype price of 2Seventy Bio is based on 3 months time horizon.

2Seventy Bio Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as 2Seventy Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 2Seventy Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with 2Seventy Bio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.07 
4.15
 0.00  
  0.03 
10 Events / Month
17 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.99
4.01
0.00 
41,500  
Notes

2Seventy Bio Hype Timeline

2Seventy Bio is at this time traded for 3.99. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. 2Seventy is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at -0.07%. %. The volatility of related hype on 2Seventy Bio is about 845.44%, with the expected price after the next announcement by competition of 3.96. About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.9. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. 2Seventy Bio recorded a loss per share of 1.83. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days.
Check out 2Seventy Bio Basic Forecasting Models to cross-verify your projections.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

2Seventy Bio Related Hype Analysis

Having access to credible news sources related to 2Seventy Bio's direct competition is more important than ever and may enhance your ability to predict 2Seventy Bio's future price movements. Getting to know how 2Seventy Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how 2Seventy Bio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ICPTIntercept Pharmaceuticals 0.66 3 per month 0.00 (0.17) 5.23 (8.32) 38.17 
PBYIPuma Biotechnology(0.03)7 per month 4.07  0.08  5.17 (4.95) 33.65 
IOVAIovance Biotherapeutics 0.34 8 per month 0.00 (0.07) 7.54 (6.95) 23.06 
SRPTSarepta Therapeutics(4.00)10 per month 1.98 (0.05) 3.75 (3.10) 9.65 
DAWNDay One Biopharmaceuticals 0.27 10 per month 0.00 (0.05) 3.84 (3.69) 11.44 
INZYInozyme Pharma(0.32)6 per month 0.00 (0.31) 5.07 (7.92) 16.62 
ZNTLZentalis Pharmaceuticals Llc 0.05 9 per month 5.06  0.05  11.41 (8.64) 33.76 
SNDXSyndax Pharmaceuticals 0.06 7 per month 0.00 (0.09) 4.02 (4.33) 34.00 
PTGXProtagonist Therapeutics(2.63)10 per month 2.29  0  3.70 (3.74) 14.61 
THRXTheseus Pharmaceuticals 0.14 2 per month 0.00 (0.06) 11.75 (8.57) 90.33 
CGEMCullinan Oncology LLC(0.23)9 per month 0.00 (0.17) 5.88 (7.24) 17.85 
MRSNMersana Therapeutics(0.14)7 per month 5.09  0.09  12.03 (9.72) 32.25 
RLAYRelay Therapeutics(0.03)11 per month 0.00 (0.07) 4.82 (6.29) 66.18 
RCUSArcus Biosciences(0.12)9 per month 0.00 (0.06) 7.43 (5.85) 17.22 
STOKStoke Therapeutics(0.04)10 per month 0.00 (0.08) 4.68 (6.99) 21.35 
KZRKezar Life Sciences(0.20)7 per month 2.77  0.04  4.93 (3.88) 51.13 
PHATPhathom Pharmaceuticals(0.61)6 per month 0.00 (0.13) 6.89 (6.83) 35.62 
REPLReplimune Group 0.02 9 per month 3.38  0.09  8.25 (6.02) 46.30 
KDNYChinook Therapeutics(0.12)2 per month 1.72  0.12  4.20 (4.64) 58.95 
DICEDice Molecules Holdings 0.02 7 per month 1.14  0.11  5.66 (2.91) 37.64 
PLRXPliant Therapeutics 0.22 9 per month 3.11 (0) 5.37 (5.55) 24.35 
CRNXCrinetics Pharmaceuticals(1.87)11 per month 2.47 (0) 3.67 (3.45) 16.75 
ASNDAscendis Pharma AS(2.73)8 per month 2.76 (0.03) 4.75 (3.56) 22.16 

2Seventy Bio Additional Predictive Modules

Most predictive techniques to examine 2Seventy price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for 2Seventy using various technical indicators. When you analyze 2Seventy charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About 2Seventy Bio Predictive Indicators

The successful prediction of 2Seventy Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as 2Seventy Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of 2Seventy Bio based on analysis of 2Seventy Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to 2Seventy Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to 2Seventy Bio's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding113.7783.6148.7651.69
PTB Ratio1.681.080.820.78

Story Coverage note for 2Seventy Bio

The number of cover stories for 2Seventy Bio depends on current market conditions and 2Seventy Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that 2Seventy Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about 2Seventy Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

2Seventy Bio Short Properties

2Seventy Bio's future price predictability will typically decrease when 2Seventy Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of 2Seventy Bio often depends not only on the future outlook of the potential 2Seventy Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 2Seventy Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.3 M
Cash And Short Term Investments217 M

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.